Antitumoral Potential of the Histone Demethylase Inhibitor GSK-J4 in Retinoblastoma. Zhang Y, Wu W, Xu C, Yang H, et al. Invest Ophthalmol Vis Sci 2024;65:34.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang Y, Wu W, Xu C, Yang H, et al. Antitumoral Potential of the Histone Demethylase Inhibitor GSK-J4 in Retinoblastoma. Invest Ophthalmol Vis Sci 2024;65:34.
PMID: 38393716